Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA crosslinking at the guanine N7 position refers to the formation of covalent bonds between two nucleotides in DNA, specifically involving the nitrogen atom at position 7 (N7) of guanine bases. This site is highly nucleophilic and exposed in the major groove of double-helical DNA, making it a frequent target for alkylating agents and crosslinking chemicals. Crosslinking at this site can inhibit replication and transcription, leading to cell death, and is exploited in some chemotherapies. While N7-Guanine adducts can serve as sensitive biomarkers for exposure to carcinogens, they are generally considered non-promutagenic due to their instability.
Covalent modification of DNA, leading to interstrand or intrastrand crosslinks.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Crosslinking at Guanine N7 Position.